Status:
COMPLETED
Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain
Lead Sponsor:
Alexandria University
Conditions:
Pain, Postoperative
Breast Cancer
Eligibility:
FEMALE
30-65 years
Phase:
PHASE4
Brief Summary
in this study we are investigating the role of instillation of Bupivacaine through surgical drains at the end of mastectomy surgeries in controlling post operative pain and decreasing their pain kille...
Detailed Description
patients were enrolled into 2 groups. in one group the wound was installed by 40ml of 0.25% bupivacaine through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 2...
Eligibility Criteria
Inclusion
- female patients with unilateral breast cancer candidates for total mastectomy and axillary dissection
Exclusion
- Male patients
- Bilateral breast cancer.
- Patients with a history of a long duration of NSAID intake or other painkillers, drug abuse
- Patients with chest wall pain like Tietze syndrome, history of angina pectoris or recent HZV infection.
- Patients with known psychological or mental problems.
- Patients who were not exposed to axillary dissection
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT03799757
Start Date
January 1 2016
End Date
December 1 2018
Last Update
January 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Main Univeristy Hospital
Alexandria, Egypt